Fig. 2. The effect of genetic risk (CXCR3 ligands) on severe chronic graft-versus-host disease (GVHD).
A Association of the combined genetic risk group with the incidence of severe chronic GVHD in the training cohort and validation cohort. B No difference could be observed between the genetic risk groups in patients with SEP in two consecutive cohorts (n = 144 and 159, respectively). C Association of serum CXCL9 levels at day +28 with the combined genetic risk group in patients without and with SEP. n.s. not significant; *P ≤ 0.05.